Insulin, epidemiology, pathophysiology and common sense
One can say there are two (complementary) ways to ascertain the plausibility of a causal relation between a "risk factor" and a disease: finding arguments within, and finding arguments outside the epidemiological field. Epidemiology has pointed to insulin as an independent and weakly but statistically significant prospective correlate of CHD in three cohorts of middle-aged men [1] [2] [3] . The fact that the correlate (fasting insulin or stimulated insulin) could vary between [1, 3] and even within studies [3, 4] Abbreviations: CHD, Coronary heart disease; NIDDM, noninsulin dependent diabetes mellitus.
ably constitutes a random finding, due to variability artifacts that are known to occur in multivariate analyses, rather than an inconsistency, and in any case does not alter the interpretation given the high correlation coefficients between the two measures in a healthy population. The arguments against causality need not therefore be sought through a detailed critical review of the three above-mentioned studies. It is sufficient to remark that the result has been found so far only in healthy male middle-aged cohorts.
That the correlation between plasma insulin levels and CHD was not evidenced in the Pima Indians [5] is no wonder: this population group experience so little cardiovascular disease as to render the search for subtle risk factors extremely difficult, if not meaningless. Far more interesting is the fact that the association has never been proven in women [2, 6] , nor seemingly in elderly men [7] . Inconsistent results in cohorts of diabetic or glucose-intolerant subjects also plead in favour of an absence of a causal relationship between hyperinsulinaemia and CHD [8] .
If an excess of circulating insulin was actually toxic for the arteries, it would be difficult (though not impossible -specific protective factors in the female? Survival biases in the elderly?) to explain why this toxicity be expressed only in middle-aged non-diabetic men. Hence, epidemiology itself provides arguments against a causal relationship between insulin and cardiovascular disease.
From outside the field of epidemiology come arguments of another kind. Few biological studies have demonstrated a direct deleterious effect of insulin or insulin-like factors on the arterial wall -essentially a proliferation of muscle cells in the media, generally observed with insulin perfusions far above the physiological range [9] . On the other hand several clinical studies have shown, and this is acknowledged by Jarrett himself as "'ample evidence", that hyperinsulinaemia is generally associated with a cluster of "well-documented risk factors for CHD", among which are elevated blood pressure, low HDL-cholesterol levels and high triglycerides. This raises the possibility that hyperinsulinaemia appears to be linked to an increased cardiovascular risk because it indicates the presence of this cluster of plausibly atherogenic abnormalities. The question now is: why only in male middle-aged non-diabetic Caucasians?
Jarrett proposes a somewhat surprising answer to this question, by assigning to hyperinsulinaemia a protective role against the deleterious effects of the "well-documented risk factors" to which it is associated. It is always difficult to derive pathophysiological explanations directly from epidemiological correlations, as we have just seen, but this hypothesis certainly challenges one's common sense. If it were to be accepted, an alternative explanation would be needed to account for the negative correlation of HDL-cholesterol (a protective factor which increases -epidemiologically speaking -with total cholesterol) with cardiovascular events.
More reasonably, one could suggest that high levels of circulating insulin may not always be the best indicator of the above-mentioned cluster of risk factors. For instance, it is well known that hyperinsulinaemia and obesity go hand in hand, which would mean rather "android" (centrally-distributed) obesity in men, and "gynoid" (peripherally-distributed) obesity in women. Jarrett is right to point out that an excess of visceral fat, typical of android obesity, is indeed associated with a greater risk of cardiovascular events, both in men and women [10] , and it is actually together with android obesity that the cluster of cardiovascular risk factors can most easily be found [11] . Since in epidemiological cohorts hyperinsulinaemic women are generally gynoid obese and therefore not excessively at risk for cardiovascular disease, plasma insulin levels cannot be expected to relate to CHD.
In NIDDM subjects -who are typically android obese -, hyperinsulinaemia is generally present, together with the accompanying cluster of risk factors. However, as the duration of the glycaemic disorder increases, the levels of plasma insulin decrease [12] , and this hardly qualifies them, from a statistical point of view, for a positive correlation with cardiovascular events. Indeed, the best indicator of the cluster of CHD risk factors in this case appears to be a more markedly android distribution of fat and a higher level of plasma triglycerides, which are the strongest predictors of CHD mortality in diabetic and glucose-intolerant subjects [13] .
All this may readily account for what Jarrett calls '"inconsistencies" in the relationship between insulin and cardiovascular disease. Plasma insulin is not the most ubiquitous indicator of the existence of a potentially atherogenic syndrome. As its measurement is relatively time-consuming, expensive and poorly specific, a suggestion could be to replace it with a much A. Fontbonne: High insulin levels a risk for coronary heart disease? cheaper and easier one: the measurement of the waist and the hip circumferences, the ratio of which gives a pretty good idea of the distribution of body fat,
Insulin, not insulin, and the "small baby" hypothesis
In the last paragraph of his article, Jarrett briefly mentions two recent British contributions more or less related to the topic of insulin and cardiovascular disease. The first one concerns the imprecisions of the radioimmunological assay of insulin, the one commonly used in epidemiological studies, which does not distinguish between "true" insulin and its much less active precursors [14] . This may provide an explanation to the fact that "hyperinsulinaemic" men appear insulin resistant (they may have a lesser proportion of active insulin compared to "normoinsulinaemic" men). However, it is to be remembered that in diabetic or glucose-intolerant subjects, supposedly the most deficient in active insulin despite usually "hyperinsulinaemic", plasma "total insulin-like molecules" are seldom if ever associated with cardiovascular complications, as we and Jarrett himself, in the first part of his paper, have mentioned.
The hypothesis of Hales and Barker [15] of a fetal programming of future disease in adulthood is also mentioned by Jarrett, though it seems peripheral to the present issue (unless Jarrett would now accuse insulin or its precursors to be risk determinants of cardiovascular complications?). It is also extremely questionable, since Hales and Barker's observations were made on groups of elderly subjects, whose childhood took place immediately before or during the Second World War. Could it simply be that "small babies" with little or no capacity for storing fat did not survive the harsh circumstances of their childhood? Hence "small babies" who survived (studied much later by Barker) are more prone to obesity, NIDDM and cardiovascular disease later in life? And that actually a cluster of risk factors would protect "'small babies"?
Conclusion
Finally, Jarrett's article, though it may appear to verge on the polemic, proves that a kind of consensus has emerged between researchers in the field. Epidemiology has led us to identify (some may say: to rediscover, but this is another debate) an "at-risk" situation, i. e. the cluster of potentially atherogenic abnormalities generally associated with android obesity. Causality in the relationship between this cluster and cardiovascular events is plausible, since for at least some of its elements -and the list is not final -there exist physiological observations which constitute stronger arguments for a deleterious effect on arteries than is the case for insulin [16] . Having put insulin on trial has served a double aim: it has found no evidence of guilt, and it has revealed that high levels of the hormone can nevertheless indicate a situation of greater cardiovascular risk, usually associated with an android distribution of body fat.
